T- and B-lymphocyte subpopulations following radiotherapy for invasive squamous cell carcinoma of the uterine cervix - PubMed (original) (raw)
- PMID: 309370
- PMCID: PMC1537508
T- and B-lymphocyte subpopulations following radiotherapy for invasive squamous cell carcinoma of the uterine cervix
R J Rand et al. Clin Exp Immunol. 1978 Jul.
Abstract
Lymphocyte subpopulations in patients with cervical carcinoma were studied before and after radiotherapy. T lymphocytes were recognized by their ability to form spontaneous rosettes with sheep erythrocytes (E rosettes). Two surface marker characteristics were used to detect B lymphocytes: receptors for activated complement responsible for erythrocyte--antibody--complement (EAC) rosette formation, and surface membrane immunoglobulin (SmIg), readily stainable by immunofluorescence. We have demonstrated a significant depression of total lymphocytes after radiotherapy which persists for more than 5 years. This reduction in lymphocytes is due to a loss of E rosette-forming T cells, SmIg-bearing B cells and null cells. Absolute numbers of EAC rosette-forming B cells are not altered by treatment, and there is a rise in this cell type when the results are expressed as percentages of the total lymphocyte count. The possible functional immunological significance of these changes is discussed.
Similar articles
- T- and B-lymphocyte subpopulations in pre-invasive and invasive carcinoma of the cervix.
Rand RJ, Jenkins DM, Bulmer R. Rand RJ, et al. Clin Exp Immunol. 1977 Dec;30(3):421-8. Clin Exp Immunol. 1977. PMID: 304787 Free PMC article. - T and B lymphocytes of the regional lymph nodes in patients with carcinoma of uterine cervix.
Ilyin NV, Dexter LI, Bochman YaV. Ilyin NV, et al. Neoplasma. 1979;26(4):423-7. Neoplasma. 1979. PMID: 392325 - Age-dependent changes of human blood lymphocyte subpopulations.
Clot J, Charmasson E, Brochier J. Clot J, et al. Clin Exp Immunol. 1978 May;32(2):346-51. Clin Exp Immunol. 1978. PMID: 307469 Free PMC article. - Characterization of human peripheral blood lymphocyte cells on the basis of surface properties.
Negro Alvarez JM. Negro Alvarez JM. Allergol Immunopathol (Madr). 1980 Nov-Dec;8(6):679-84. Allergol Immunopathol (Madr). 1980. PMID: 7010971 Review. - Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J, Bitter K, Nicklisch U. Bier J, et al. J Maxillofac Surg. 1978 May;6(2):75-93. doi: 10.1016/s0301-0503(78)80074-5. J Maxillofac Surg. 1978. PMID: 353210 Review.
Cited by
- Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, McAvoy S, McAleer MF, Lin SH, Li J, Ghia AJ, Zhu C, Sulman EP, de Groot JF, Heimberger AB, McGovern SL, Grassberger C, Shih H, Ellsworth S, Grosshans DR. Mohan R, et al. Neuro Oncol. 2021 Feb 25;23(2):284-294. doi: 10.1093/neuonc/noaa182. Neuro Oncol. 2021. PMID: 32750703 Free PMC article. Clinical Trial. - Blood lymphocyte subpopulations in breast cancer patients following post-operative adjuvant chemotherapy or radiotherapy.
Petrini B, Wasserman J, Blomgren H, Baral E, Strender LE, Wallgren A. Petrini B, et al. Clin Exp Immunol. 1979 Nov;38(2):361-5. Clin Exp Immunol. 1979. PMID: 527268 Free PMC article. Clinical Trial. - Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment.
D'Auria F, Statuto T, Rago L, Montagna A, Castaldo G, Schirò I, Zeccola A, Virgilio T, Bianchino G, Traficante A, Sgambato A, Fusco V, Valvano L, Calice G. D'Auria F, et al. Front Oncol. 2022 Jun 1;12:829812. doi: 10.3389/fonc.2022.829812. eCollection 2022. Front Oncol. 2022. PMID: 35719968 Free PMC article. - Mutations of the human interferon alpha-2b (hIFNα-2b) gene in cancer patients receiving radiotherapy.
Shahid S, Chaudhry MN, Mahmood N. Shahid S, et al. Am J Cancer Res. 2015 Jul 15;5(8):2455-66. eCollection 2015. Am J Cancer Res. 2015. PMID: 26396921 Free PMC article. - Hypofractionated radiotherapy with simultaneous integrated boost for localized prostate cancer patients: effects on immune system and prediction of toxicity.
D'Auria F, Valvano L, Calice G, D'Esposito V, Cabaro S, Formisano P, Bianchino G, Traficante A, Bianculli A, Lazzari G, Statuto T, Rago L. D'Auria F, et al. Front Immunol. 2024 Oct 28;15:1457839. doi: 10.3389/fimmu.2024.1457839. eCollection 2024. Front Immunol. 2024. PMID: 39530099 Free PMC article.
References
- Blood. 1963 May;21:605-19 - PubMed
- Int J Radiat Oncol Biol Phys. 1976 Jan-Feb;1(3-4):177-88 - PubMed
- Clin Exp Immunol. 1977 Jul;29(1):36-42 - PubMed
- Clin Exp Immunol. 1977 Dec;30(3):421-8 - PubMed
- Cancer Res. 1976 Sep;36(9 pt.1):3274-8 - PubMed